VREOF · Vireo Growth Inc.

MINNEAPOLIS and LONG BEACH, Calif., April 13, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Glass House Brands Inc. (“Glass House”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced a joint venture to build one of California's largest and most strategically positioned cannabis retail platforms. Following regulatory and certain closing conditions, each company will contribute its California dispensary operations to the joint entity in exchange for a 50% ownership interest. Vireo operates twelve dispensaries and home delivery operations recently acquired from Eaze, Inc. (“Eaze”). Glass House currently operates eleven California retail locations. Together, the combined network will be supported by a preferential supply agreement with Glass House, California's most efficient large-scale cannabis producer. After five years, Vireo will have the option to acquire Glass House’s equity interest in the joint venture, and

Transaction further strengthens the Company’s balance sheet with approximately US$110 million of combined cash and net working capital Consideration of 213 million shares at a deemed price of US$0.60 and 80 million warrants at US$0.85 strike price Company has nominated Scotts Miracle-Gro EVP Chris Hagedorn for election to its Board of Directors MINNEAPOLIS, April 08, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it has completed the acquisition of The Hawthorne Gardening Company LLC (including certain of its subsidiaries, “Hawthorne”), a leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America from The Scotts Miracle-Gro Company (“ScottsMiracle-Gro”) (the “Hawthorne Transaction”). As a result of the Hawthorne Transaction, Vireo acquired US$35 million of cash held by Hawthorne, approximately US$58 million of net working capital, and US$20 million of

Majority ownership of Vireo Health of New York to transfer to MWBE-led Ace Ventures; partnership reinforces long-term alignment with New York’s social equity framework MINNEAPOLIS, April 03, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) today announced a strategic partnership with Ace Venture of NY, LLC (“Ace”), a New York-based Minority & Women-Owned Business Enterprise led by lifelong New Yorker Steven Acevedo, to establish what is expected to become New York’s first scaled social equity operator emerging from the state’s first minority-owned vertically integrated medical cannabis license. The partnership was developed under the leadership of Chief Executive Officer John Mazarakis and reflects Vireo’s commitment to advancing New York’s vision for a responsible, inclusive, and community-oriented cannabis industry. Under the agreement, Ace will assume a 51% ownership interest in Vireo Health of New York, LLC (“Vireo NY”), establishing a majority

Transaction expands Vireo’s operating footprint to 10 states with over 160 dispensaries and approximately 800,000 sq. ft. of cultivation and production Acquisition adds two new markets, California and Florida, and an incremental 15 dispensaries to the Company’s retail footprint in Colorado Eaze’s delivery platform expected to enhance Company’s IP portfolio with a robust presence in California Cory Azzalino announced as the CEO of Vireo’s California business MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it has closed its acquisition of Eaze Inc. (“Eaze”), a vertically-integrated cannabis retailer and delivery technology platform with operations in California, Florida and Colorado. Eaze has 67 active retail locations and has completed over 12 million deliveries. Chief Executive Officer John Mazarakis commented, “We are thrilled to announce the closing of our Eaze acquisition and Vireo’s entrance

Management Services Agreement went into effect on March 22, 2026, allowing Vireo to manage certain PharmaCann Colorado assets through closing, which is expected in Q2’26 MINNEAPOLIS, March 30, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced an update on its previously disclosed Asset Purchase Agreement (“APA”) to acquire certain retail assets and properties of PharmaCann Inc. (“PharmaCann”) in the State of Colorado. On December 16, 2025, the Company announced entry into the APA and a Management Services Agreement (the “MSA”), pursuant to which the Company’s affiliate will provide certain affiliates of PharmaCann with certain management services related to PharmaCann’s retail assets in Colorado until the closing date. The Company announced today that the MSA became effective on March 22, 2026 and pursuant to the terms of the APA, the Company delivered 90,740,741 subordinate voting shares of the Company from treasury into

Planned share-based transaction is expected to be completed during the second quarter of 2026 Vireo plans to appoint ScottsMiracle-Gro EVP Chris Hagedorn to its Board of Directors MINNEAPOLIS, March 30, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced an update on its previously announced nonbinding Memorandum of Understanding (“MOU”) with The Scotts Miracle-Gro Company (“ScottsMiracle-Gro”) to acquire The Hawthorne Gardening Company LLC (including certain of its subsidiaries, “Hawthorne”), an operating subsidiary of ScottsMiracle-Gro and leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America (the “Hawthorne Transaction”). The Hawthorne Transaction could close any time following five (5) business days following the date of this announcement, subject to the conditions described below. The material details of the transaction are expected to be substantially

– Vireo acquires 24 dispensaries in Colorado, 21 dispensaries in New Mexico and 1 manufacturing facility in each of Colorado and New Mexico at an assumed share price of $0.661 – Justin Dye to become Chairman of Vireo’s Colorado and New Mexico business – Forrest Hoffmaster announced as CEO of Vireo’s Colorado and New Mexico business MINNEAPOLIS, March 24, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF) today announced the closing of its previously disclosed acquisition of certain assets of U.S. multi-state cannabis operator Medicine Man Technologies, Inc. (dba “Schwazze”). John Mazarakis, Chief Executive Officer of Vireo, commented, “We are pleased to announce the closing of the acquisition of the Schwazze assets. This transaction represents a meaningful step in the continued execution of our disciplined growth strategy, enabling Vireo to expand its presence in key markets through the acquisition of established retail operations at an

Q4 GAAP revenue of $104.5 million increased 317.7% year-over-year, driven by recently closed M&A transactions On a pro forma basis, Q4 same store sales increased 22% year-over-year and wholesale revenue increased 55% year-over-year; excluding Minnesota, same store sales increased 11.3% year-over-year Announced the pending acquisitions of Eaze, Schwazze, and PharmaCann retail assets in Colorado, and MOU for the acquisition of Hawthorne, all of which are expected to close in the first half of 2026 Company closed Q4 with $122.5 million in cash; expects to remain acquisitive MINNEAPOLIS, March 17, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today reported financial results for its fourth fiscal quarter ended December 31, 2025. Key financial results are presented below in summary form with supporting commentary and discussion from management of certain key operating metrics which the Company uses to judge its performance. All currency

MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its fourth quarter and full fiscal year ended December 31, 2025 on Tuesday, March 17, 2026, before the market opens. Vireo Growth management will host a conference call with the investment community that same day, Tuesday, March 17, 2026, at 8:00 a.m. ET (7:00 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 9471311. A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link: https://events.q4inc.com/attendee/171708452 . About Vireo Growth Inc. Vireo was founded in 2014 as a pioneering medical cannabis company. Vireo is

Planned share-based transaction is expected to be completed during the first fiscal quarter of 2026 Vireo plans to appoint Chris Hagedorn to its Board of Directors MINNEAPOLIS, Jan. 28, 2026 (GLOBE NEWSWIRE) - Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it has entered into a nonbinding Memorandum of Understanding (“MOU”) with The Scotts Miracle-Gro Company to acquire The Hawthorne Gardening Company LLC (“Hawthorne”), an independent operating subsidiary of ScottsMiracle-Gro and leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America. John Mazarakis, Chief Executive Officer of Vireo, commented, “We’ve valued our working relationship with ScottsMiracle-Gro and the Hawthorne team, and they have been excellent to work with throughout our discussions. This proposed transaction builds on a foundation of mutual respect and trust developed over time.” Vireo intends to name